Celltrion
068270.KS
#749
Rank
ยฃ21.66 B
Marketcap
ยฃ105.36
Share price
1.25%
Change (1 day)
6.91%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: ยฃ21.66 Billion

As of December 2024 Celltrion has a market cap of ยฃ21.66 Billion. This makes Celltrion the world's 749th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ21.66 B-17.56%
2023ยฃ26.27 B75.36%
2022ยฃ14.98 B-12.76%
2021ยฃ17.17 B-48.07%
2020ยฃ33.08 B117.86%
2019ยฃ15.18 B-22.39%
2018ยฃ19.56 B2.73%
2017ยฃ19.04 B116.17%
2016ยฃ8.81 B61.54%
2015ยฃ5.45 B134.46%
2014ยฃ2.32 B7.57%
2013ยฃ2.16 B-19.56%
2012ยฃ2.68 B14.44%
2011ยฃ2.34 B5.2%
2010ยฃ2.23 B174.03%
2009ยฃ0.81 B48.09%
2008ยฃ0.55 B5752.02%
2007ยฃ9.4 M

End of Day market cap according to different sources

On Dec 2nd, 2024 the market cap of Celltrion was reported to be:

ยฃ21.33 Billion
by Yahoo Finance info icon info icon
ยฃ21.33 Billion
by CompaniesMarketCap info icon info icon